Benefits and opportunities of the transgenic Oncopig cancer model

Kirtan Joshi(University of Missouri), Satyanarayana Rachagani(University of Missouri), Jeffrey N. Bryan(Missouri College), Jussuf T. Kaifi(Unknown), Bhanu P. Telugu(University of Missouri), Randall S. Prather(University of Missouri), Timothy J. Hoffman(University of Missouri)

Trends in cancer

January 29, 2024

10.1016/j.trecan.2024.01.005

Cited by 7

Related Papers

RNA cargos in extracellular vesicles derived from blood serum in pancreas associated conditions

|Scientific Reports|2020|88

PD-L1 Expression with Epithelial Mesenchymal Transition of Circulating Tumor Cells Is Associated with Poor Survival in Curatively Resected Non-Small Cell Lung Cancer

|Cancers|2019|77

Targeted Mutation of NGN3 Gene Disrupts Pancreatic Endocrine Cell Development in Pigs

|Scientific Reports|2018|34

Angiogenesis index CD105 (endoglin)/CD31 (PECAM-1) as a predictive factor for invasion and proliferation in intraductal papillary mucinous neoplasm (IPMN) of the pancreas.

|PubMed|2010|27

Pigs: Large Animal Preclinical Cancer Models

|World Journal of Oncology|2024|22